2012-2022 Report on Global Alzheimer’s Disease Market Competition, Status and Forecast, Market Size by Players, Regions, Type, Application
This report studies the Alzheimer’s Disease Drug market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Alzheimer’s Disease Drug market by product type and applicationsend industries.
In the last several years, global market of alzheimer’s disease drug change huge. In 2016, global revenue of alzheimer’s disease drug is nearly 3161.3 M USD. And the global growth rate is at -10.95% from 2012 to 2016
The major players in global Alzheimer’s Disease Drug market include
In the last several years, global market of alzheimer’s disease drug change huge. In 2016, global revenue of alzheimer’s disease drug is nearly 3161.3 M USD. And the global growth rate is at -10.95% from 2012 to 2016
The major players in global Alzheimer’s Disease Drug market include
- Allergan
- Eisai
- Novartis
- Daiichi Sankyo
- Merz Pharma
- Pfizer
- Johnson & Johnson
- Lundbeck.
- North America
- Europe
- China
- Japan
- Row
- Donepezil
- Memantine
- Rivastigmine
- Early to Moderate Stages
- Moderate to Severe Stages
1 SUMMARY
1.1 Disease Definition
1.2 Key AD Statistics
1.3 Current Treatment
1.4 Research Investment
1.5 Key Research Areas
2 DISEASE BURDEN
2.1 Overview
2.2 Disease Burden
2.2.1 Population Burden of Alzheimer’s disease
.2.2.2 Economic Burden of Alzheimer’s disease
2.3 Risk Factors of Alzheimer’s disease
2.4 Biology
2.4.1 Cause of Alzheimer’s disease
Table Cause of Alzheimer’s disease
2.4.2 Progression of Alzheimer’s disease
2.5 Treatments for Alzheimer’s disease
3 GLOBAL ALZHEIMER’S DISEASE DRUG MARKET COMPETITION BY MANUFACTURERSBRAND
3.1 Global Alzheimer’s Disease Drug Sales (M Units) and Share by Manufacturers (2012-2017)
3.2 Global Alzheimer’s Disease Drug Revenue (M USD) and Share by Manufacturers (2012-2017)
3.3 Global Alzheimer’s Disease Drug Average Price (USDUnit) by Manufacturers (2012-2017)
3.4 Manufacturers Alzheimer’s Disease Drug Headquarters, Found Date, Product Types
3.5 Alzheimer’s Disease Drug Market Competitive Situation and Trends
3.5.1 Alzheimer’s Disease Drug Market Concentration Rate
3.5.2 Alzheimer’s Disease Drug Market Share (%) of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL ALZHEIMER’S DISEASE DRUG SALES (M UNITS), REVENUE (M USD) BY REGIONS (2012-2017)
4.2 Global Alzheimer’s Disease Drug Sales (M Units) and Market Share (%) by Regions (2012-2017)
4.3 Global Alzheimer’s Disease Drug Revenue (M USD) and Market Share (%) by Regions (2012-2017)
4.3 Global Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
4.5 North America Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
4.6 Europe Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
4.7 China Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
4.8 Japan Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (2012-2017)
5 GLOBAL ALZHEIMER’S DISEASE DRUG SALES, REVENUE, PRICE TREND BY TYPES
5.1 Global Alzheimer’s Disease Drug Sales (M Units) and Market Share (%) by Types (2012-2017)
5.2 Global Alzheimer’s Disease Drug Revenue and Market Share (%) by Types (2012-2017)
5.3 Global Alzheimer’s Disease Drug Price (USDUnit) by Type (2012-2017)
5.4 Global Alzheimer’s Disease Drug Sales Growth by Type (2012-2017)
6 GLOBAL ALZHEIMER’S DISEASE DRUG MARKET ANALYSIS BY APPLICATIONS
6.1 Global Alzheimer’s Disease Drug Sales (M Units) and Market Share (%) by Applications (2012-2017)
6.2 Global Alzheimer’s Disease Drug Sales Growth Rate (%) by Applications (2012-2017)
7 ANALYSIS OF ALZHEIMER’S DISEASE DRUG INDUSTRY KEY MANUFACTURERS
7.1 Allergan
7.1.1 Company Profile
7.1.2 Product Information
7.1.3 Sales, Price, Cost, Gross, and Revenue
7.2 Eisai
7.2.1 Company Profile
7.2.2 Product Information
7.2.3 Sales, Price, Cost, Gross, and Revenue
7.3 Novartis
7.3.1 Company Profile
7.3.2 Product Information
7.3.3 Sales, Price, Cost, Gross, and Revenue
7.4 Daiichi Sankyo
7.4.1 Company Profile
7.4.2 Product Information
7.4.3 Sales, Price, Cost, Gross, and Revenue
7.5 Merz Pharma
7.5.1 Company Profile
7.5.2 Product Information
7.5.3 Sales, Price, Cost, Gross, and Revenue
7.6 Pfizer
7.6.1 Company Profile
7.6.2 Product Information
7.6.3 Sales, Price, Cost, Gross, and Revenue
7.7 Johnson & Johnson
7.7.1 Company Profile
7.7.2 Product Information
7.7.3 Sales, Price, Cost, Gross, and Revenue
7.8 Lundbeck
7.8.1 Company Profile
7.8.2 Product Information
7.8.3 Sales, Price, Cost, Gross, and Revenue
8 GLOBAL ALZHEIMER’S DISEASE DRUG MARKET FORECAST (2017-2022)
8.1 Global Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD) Forecast (2017-2022)
8.1.1 Global Alzheimer’s Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
8.1.2 Global Alzheimer’s Disease Drug Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
8.1.3 Global Alzheimer’s Disease Drug Price and Trend Forecast (2017-2022)
8.2 Global Alzheimer’s Disease Drug Sales (M Units) and Revenue (M USD) Forecast by Regions (2017-2022)
8.2.1 North America Alzheimer’s Disease Drug Sales (M Units) and Revenue (M USD) Forecast (2017-2022)
8.2.2 Europe Alzheimer’s Disease Drug Sales (M Units) and Revenue (M USD) Forecast (2017-2022)
8.2.3 China Alzheimer’s Disease Drug Sales (M Units) and Revenue (M USD) Forecast (2017-2022)
8.2.4 Japan Alzheimer’s Disease Drug Sales (M Units) and Revenue (M USD) Forecast (2017-2022)
8.3 Global Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) Forecast by Type (2017-2022)
8.4 Global Alzheimer’s Disease Drug Sales (M Units) Forecast by Application (2017-2022)
9 ALZHEIMER’S DRUG-DEVELOPMENT PIPELINE
9.1 Phase III
9.2 Phase II
9.3 Phase I
9.4 Biomarkers
10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORSTRADERS
10.1 Marketing Channel
10.2 Market Positioning
10.2.1 Market Positioning
10.2.2 Brand Strategy
10.3 DistributorsTraders List
11 RESEARCH FINDINGS AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 MethodologyResearch Approach
12.1.1 Research ProgramsDesign
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Disclaimer
12.4 Author List
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1.1 Disease Definition
1.2 Key AD Statistics
1.3 Current Treatment
1.4 Research Investment
1.5 Key Research Areas
2 DISEASE BURDEN
2.1 Overview
2.2 Disease Burden
2.2.1 Population Burden of Alzheimer’s disease
.2.2.2 Economic Burden of Alzheimer’s disease
2.3 Risk Factors of Alzheimer’s disease
2.4 Biology
2.4.1 Cause of Alzheimer’s disease
Table Cause of Alzheimer’s disease
2.4.2 Progression of Alzheimer’s disease
2.5 Treatments for Alzheimer’s disease
3 GLOBAL ALZHEIMER’S DISEASE DRUG MARKET COMPETITION BY MANUFACTURERSBRAND
3.1 Global Alzheimer’s Disease Drug Sales (M Units) and Share by Manufacturers (2012-2017)
3.2 Global Alzheimer’s Disease Drug Revenue (M USD) and Share by Manufacturers (2012-2017)
3.3 Global Alzheimer’s Disease Drug Average Price (USDUnit) by Manufacturers (2012-2017)
3.4 Manufacturers Alzheimer’s Disease Drug Headquarters, Found Date, Product Types
3.5 Alzheimer’s Disease Drug Market Competitive Situation and Trends
3.5.1 Alzheimer’s Disease Drug Market Concentration Rate
3.5.2 Alzheimer’s Disease Drug Market Share (%) of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL ALZHEIMER’S DISEASE DRUG SALES (M UNITS), REVENUE (M USD) BY REGIONS (2012-2017)
4.2 Global Alzheimer’s Disease Drug Sales (M Units) and Market Share (%) by Regions (2012-2017)
4.3 Global Alzheimer’s Disease Drug Revenue (M USD) and Market Share (%) by Regions (2012-2017)
4.3 Global Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
4.5 North America Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
4.6 Europe Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
4.7 China Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
4.8 Japan Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (2012-2017)
5 GLOBAL ALZHEIMER’S DISEASE DRUG SALES, REVENUE, PRICE TREND BY TYPES
5.1 Global Alzheimer’s Disease Drug Sales (M Units) and Market Share (%) by Types (2012-2017)
5.2 Global Alzheimer’s Disease Drug Revenue and Market Share (%) by Types (2012-2017)
5.3 Global Alzheimer’s Disease Drug Price (USDUnit) by Type (2012-2017)
5.4 Global Alzheimer’s Disease Drug Sales Growth by Type (2012-2017)
6 GLOBAL ALZHEIMER’S DISEASE DRUG MARKET ANALYSIS BY APPLICATIONS
6.1 Global Alzheimer’s Disease Drug Sales (M Units) and Market Share (%) by Applications (2012-2017)
6.2 Global Alzheimer’s Disease Drug Sales Growth Rate (%) by Applications (2012-2017)
7 ANALYSIS OF ALZHEIMER’S DISEASE DRUG INDUSTRY KEY MANUFACTURERS
7.1 Allergan
7.1.1 Company Profile
7.1.2 Product Information
7.1.3 Sales, Price, Cost, Gross, and Revenue
7.2 Eisai
7.2.1 Company Profile
7.2.2 Product Information
7.2.3 Sales, Price, Cost, Gross, and Revenue
7.3 Novartis
7.3.1 Company Profile
7.3.2 Product Information
7.3.3 Sales, Price, Cost, Gross, and Revenue
7.4 Daiichi Sankyo
7.4.1 Company Profile
7.4.2 Product Information
7.4.3 Sales, Price, Cost, Gross, and Revenue
7.5 Merz Pharma
7.5.1 Company Profile
7.5.2 Product Information
7.5.3 Sales, Price, Cost, Gross, and Revenue
7.6 Pfizer
7.6.1 Company Profile
7.6.2 Product Information
7.6.3 Sales, Price, Cost, Gross, and Revenue
7.7 Johnson & Johnson
7.7.1 Company Profile
7.7.2 Product Information
7.7.3 Sales, Price, Cost, Gross, and Revenue
7.8 Lundbeck
7.8.1 Company Profile
7.8.2 Product Information
7.8.3 Sales, Price, Cost, Gross, and Revenue
8 GLOBAL ALZHEIMER’S DISEASE DRUG MARKET FORECAST (2017-2022)
8.1 Global Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD) Forecast (2017-2022)
8.1.1 Global Alzheimer’s Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
8.1.2 Global Alzheimer’s Disease Drug Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
8.1.3 Global Alzheimer’s Disease Drug Price and Trend Forecast (2017-2022)
8.2 Global Alzheimer’s Disease Drug Sales (M Units) and Revenue (M USD) Forecast by Regions (2017-2022)
8.2.1 North America Alzheimer’s Disease Drug Sales (M Units) and Revenue (M USD) Forecast (2017-2022)
8.2.2 Europe Alzheimer’s Disease Drug Sales (M Units) and Revenue (M USD) Forecast (2017-2022)
8.2.3 China Alzheimer’s Disease Drug Sales (M Units) and Revenue (M USD) Forecast (2017-2022)
8.2.4 Japan Alzheimer’s Disease Drug Sales (M Units) and Revenue (M USD) Forecast (2017-2022)
8.3 Global Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) Forecast by Type (2017-2022)
8.4 Global Alzheimer’s Disease Drug Sales (M Units) Forecast by Application (2017-2022)
9 ALZHEIMER’S DRUG-DEVELOPMENT PIPELINE
9.1 Phase III
9.2 Phase II
9.3 Phase I
9.4 Biomarkers
10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORSTRADERS
10.1 Marketing Channel
10.2 Market Positioning
10.2.1 Market Positioning
10.2.2 Brand Strategy
10.3 DistributorsTraders List
11 RESEARCH FINDINGS AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 MethodologyResearch Approach
12.1.1 Research ProgramsDesign
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Disclaimer
12.4 Author List
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Table Global Alzheimer’s disease Statistics
Table Global Alzheimer’s disease Current Treatmen
Table Global Alzheimer’s disease Research Investment
Table Global Alzheimer’s disease Key Research Areas
Figure Prevalence of AD in 65+ population in the U.S.
Figure Prevalence of AD in 65+ population in the EU
Figure Prevalence of AD in 65+ population in the China
Figure Prevalence of AD in 65+ population in the Japan
Figure Prevalence of AD in 65+ population in the MEA.
Table Estimates of Annual Expenses for AD and Other Dementia
Table Risk Factors of Alzheimer’s disease
Table Progression of Alzheimer’s disease
Table Drug for Alzheimer’s disease
Table Major Manufacturers for Alzheimer’s disease Drugs and Their Brand
Table Global Alzheimer’s Disease Drug Sales (M Units) of Key Manufacturers (2012-2017)
Figure 2016 Alzheimer’s Disease Drug Sales Share (%) by Manufacturers
Figure 2017 Alzheimer’s Disease Drug Sales Share (%) by Manufacturers
Table Global Alzheimer’s Disease Drug Revenue (M USD) by Manufacturers (2012-2017)
Table 2016 Global Alzheimer’s Disease Drug Revenue Share (%) by Manufacturers
Table 2017 Global Alzheimer’s Disease Drug Revenue Share (%) by Manufacturers
Table Global Market Alzheimer’s Disease Drug Average Price (USDUnit) of Key Manufacturers (2012-2017)
Figure Global Market Alzheimer’s Disease Drug Average Price (USDUnit) of Key Manufacturers in 2016
Table Manufacturers Alzheimer’s Disease Drug Headquarters and Found Date
Table Manufacturers Alzheimer’s Disease Drug Brand
Table 2016 Global Alzheimer’s Disease Drug Revenue Share (%) by Manufacturers
Figure Alzheimer’s Disease Drug Market Share (%) of Top 3 Manufacturers
Figure Alzheimer’s Disease Drug Market Share (%) of Top 5 Manufacturers
Table Mergers & Acquisitions, Expansion
Table Global Alzheimer’s Disease Drug Sales (M Units) by Regions (2012-2017)
Table Global Alzheimer’s Disease Drug Sales Market Share by Regions (2012-2017)
Figure 2016 Global Alzheimer’s Disease Drug Sales Market Share (%) by Regions
Figure 2017 Global Alzheimer’s Disease Drug Sales Market Share (%) by Regions
Table Global Alzheimer’s Disease Drug Revenue (M USD) by Regions (2012-2017)
Table Global Alzheimer’s Disease Drug Revenue Market Share (%) by Regions (2012-2017)
Figure 2016 Global Alzheimer’s Disease Drug Revenue Market Share (%) by Regions
Figure 2017 Global Alzheimer’s Disease Drug Revenue Market Share (%) by Regions
Table Global Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
Table North America Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
Table Europe Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
Table China Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
Table Japan Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
Table Global Alzheimer’s Disease Drug Sales (M Units) by Types (2012-2017)
Table Global Alzheimer’s Disease Drug Sales Share (%) by Types (2012-2017)
Figure 2016 Sales Market Share (%) of Alzheimer’s Disease Drug by Types
Figure 2017 Sales Market Share (%) of Alzheimer’s Disease Drug by Types
Table Global Alzheimer’s Disease Drug Revenue (M USD) by Types (2012-2017)
Table Global Alzheimer’s Disease Drug Revenue Share (%) by Types (2012-2017)
Figure 2016 Revenue Market Share (%) of Alzheimer’s Disease Drug by Types
Figure 2017 Revenue Market Share (%) of Alzheimer’s Disease Drug by Types
Table Global Alzheimer’s Disease Drug Price (USDUnit) by Types (2012-2017)
Figure Global Alzheimer’s Disease Drug Sales Growth (%) by Type (2012-2017)
Table Global Alzheimer’s Disease Drug Sales (M Units) by Applications (2012-2017)
Table Global Alzheimer’s Disease Drug Sales Market Share (%) by Applications (2012-2017)
Figure Global Alzheimer’s Disease Drug Sales Market Share (%) by Applications in 2016
Figure Global Alzheimer’s Disease Drug Sales Market Share (%) by Applications in 2017
Figure Global Alzheimer’s Disease Drug Sales Growth Rate (%) by Applications (2012-2017)
Table Allergan Company Profile
Table Alzheimer’s Disease Drug Product Introduction of Allergan
Table Alzheimer’s Disease Drug Ssles (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Allergan 2012-2017
Table Eisai Company Profile
Table Alzheimer’s Disease Drug Product Introduction of Eisai
Table Alzheimer’s Disease Drug Production (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Eisai 2012-2017
Table Novartis Company Profile
Table Alzheimer’s Disease Drug Product Introduction of Novartis
Table Alzheimer’s Disease Drug Production (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Novartis 2012-2017
Table Daiichi Sankyo Company Profile
Table Alzheimer’s Disease Drug Product Introduction of Daiichi Sankyo
Table Alzheimer’s Disease Drug Production (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Daiichi Sankyo 2012-2017
Table Merz Pharma Company Profile
Table Alzheimer’s Disease Drug Product Introduction of Merz Pharma
Table Alzheimer’s Disease Drug Production (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Merz Pharma 2012-2017
Table Pfizer Company Profile
Table Alzheimer’s Disease Drug Product Introduction of Pfizer
Table Alzheimer’s Disease Drug Production (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Pfizer 2012-2017
Table Johnson & Johnson Company Profile
Table Alzheimer’s Disease Drug Product Introduction of Johnson & Johnson
Table Alzheimer’s Disease Drug Production (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Johnson & Johnson 2012-2017
Table Lundbeck Company Profile
Table Alzheimer’s Disease Drug Product Introduction of Lundbeck
Table Alzheimer’s Disease Drug Production (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Lundbeck 2012-2017
Figure Global Alzheimer’s Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
Figure Global Alzheimer’s Disease Drug Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
Figure Global Alzheimer’s Disease Drug Price and Trend Forecast (2017-2022)
Table Global Alzheimer’s Disease Drug Sales (M Units) Forecast by Regions (2017-2022)
Figure North America Alzheimer’s Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
Figure North America Alzheimer’s Disease Drug Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Europe Alzheimer’s Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
Figure Europe Alzheimer’s Disease Drug Revenue and Growth Rate (%) Forecast (2017-2022)
Figure China Alzheimer’s Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
Figure China Alzheimer’s Disease Drug Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Japan Alzheimer’s Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
Figure Japan Alzheimer’s Disease Drug Revenue and Growth Rate (%) Forecast (2017-2022)
Table Global Alzheimer’s Disease Drug Sales (M Unit) Forecast by Type (2017-2022)
Table Global Alzheimer’s Disease Drug Revenue (M USD) Forecast by Type (2017-2022)
Table Global Alzheimer’s Disease Drug Price (USDUnit) Forecast by Type (2017-2022)
Table Global Alzheimer’s Disease Drug Sales (M Units) Forecast by Application (2017-2022)
Figure Agents currently in clinical trials for AD
Table Agents currently in phase III of development and their mechanism of action
Table Agents currently in phase II of AD drug development and their mechanism of action
Table Agents currently in phase I of development and their mechanism of action
Table Percent of trials with specific biomarkers included
Figure Marketing Channel for Alzheimer’s Disease
Figure Alzheimer’s Disease Marketing Channel
Table DistributorsTraders List
Table Research ProgramsDesign for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Table Global Alzheimer’s disease Statistics
Table Global Alzheimer’s disease Current Treatmen
Table Global Alzheimer’s disease Research Investment
Table Global Alzheimer’s disease Key Research Areas
Figure Prevalence of AD in 65+ population in the U.S.
Figure Prevalence of AD in 65+ population in the EU
Figure Prevalence of AD in 65+ population in the China
Figure Prevalence of AD in 65+ population in the Japan
Figure Prevalence of AD in 65+ population in the MEA.
Table Estimates of Annual Expenses for AD and Other Dementia
Table Risk Factors of Alzheimer’s disease
Table Progression of Alzheimer’s disease
Table Drug for Alzheimer’s disease
Table Major Manufacturers for Alzheimer’s disease Drugs and Their Brand
Table Global Alzheimer’s Disease Drug Sales (M Units) of Key Manufacturers (2012-2017)
Figure 2016 Alzheimer’s Disease Drug Sales Share (%) by Manufacturers
Figure 2017 Alzheimer’s Disease Drug Sales Share (%) by Manufacturers
Table Global Alzheimer’s Disease Drug Revenue (M USD) by Manufacturers (2012-2017)
Table 2016 Global Alzheimer’s Disease Drug Revenue Share (%) by Manufacturers
Table 2017 Global Alzheimer’s Disease Drug Revenue Share (%) by Manufacturers
Table Global Market Alzheimer’s Disease Drug Average Price (USDUnit) of Key Manufacturers (2012-2017)
Figure Global Market Alzheimer’s Disease Drug Average Price (USDUnit) of Key Manufacturers in 2016
Table Manufacturers Alzheimer’s Disease Drug Headquarters and Found Date
Table Manufacturers Alzheimer’s Disease Drug Brand
Table 2016 Global Alzheimer’s Disease Drug Revenue Share (%) by Manufacturers
Figure Alzheimer’s Disease Drug Market Share (%) of Top 3 Manufacturers
Figure Alzheimer’s Disease Drug Market Share (%) of Top 5 Manufacturers
Table Mergers & Acquisitions, Expansion
Table Global Alzheimer’s Disease Drug Sales (M Units) by Regions (2012-2017)
Table Global Alzheimer’s Disease Drug Sales Market Share by Regions (2012-2017)
Figure 2016 Global Alzheimer’s Disease Drug Sales Market Share (%) by Regions
Figure 2017 Global Alzheimer’s Disease Drug Sales Market Share (%) by Regions
Table Global Alzheimer’s Disease Drug Revenue (M USD) by Regions (2012-2017)
Table Global Alzheimer’s Disease Drug Revenue Market Share (%) by Regions (2012-2017)
Figure 2016 Global Alzheimer’s Disease Drug Revenue Market Share (%) by Regions
Figure 2017 Global Alzheimer’s Disease Drug Revenue Market Share (%) by Regions
Table Global Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
Table North America Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
Table Europe Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
Table China Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
Table Japan Alzheimer’s Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
Table Global Alzheimer’s Disease Drug Sales (M Units) by Types (2012-2017)
Table Global Alzheimer’s Disease Drug Sales Share (%) by Types (2012-2017)
Figure 2016 Sales Market Share (%) of Alzheimer’s Disease Drug by Types
Figure 2017 Sales Market Share (%) of Alzheimer’s Disease Drug by Types
Table Global Alzheimer’s Disease Drug Revenue (M USD) by Types (2012-2017)
Table Global Alzheimer’s Disease Drug Revenue Share (%) by Types (2012-2017)
Figure 2016 Revenue Market Share (%) of Alzheimer’s Disease Drug by Types
Figure 2017 Revenue Market Share (%) of Alzheimer’s Disease Drug by Types
Table Global Alzheimer’s Disease Drug Price (USDUnit) by Types (2012-2017)
Figure Global Alzheimer’s Disease Drug Sales Growth (%) by Type (2012-2017)
Table Global Alzheimer’s Disease Drug Sales (M Units) by Applications (2012-2017)
Table Global Alzheimer’s Disease Drug Sales Market Share (%) by Applications (2012-2017)
Figure Global Alzheimer’s Disease Drug Sales Market Share (%) by Applications in 2016
Figure Global Alzheimer’s Disease Drug Sales Market Share (%) by Applications in 2017
Figure Global Alzheimer’s Disease Drug Sales Growth Rate (%) by Applications (2012-2017)
Table Allergan Company Profile
Table Alzheimer’s Disease Drug Product Introduction of Allergan
Table Alzheimer’s Disease Drug Ssles (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Allergan 2012-2017
Table Eisai Company Profile
Table Alzheimer’s Disease Drug Product Introduction of Eisai
Table Alzheimer’s Disease Drug Production (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Eisai 2012-2017
Table Novartis Company Profile
Table Alzheimer’s Disease Drug Product Introduction of Novartis
Table Alzheimer’s Disease Drug Production (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Novartis 2012-2017
Table Daiichi Sankyo Company Profile
Table Alzheimer’s Disease Drug Product Introduction of Daiichi Sankyo
Table Alzheimer’s Disease Drug Production (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Daiichi Sankyo 2012-2017
Table Merz Pharma Company Profile
Table Alzheimer’s Disease Drug Product Introduction of Merz Pharma
Table Alzheimer’s Disease Drug Production (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Merz Pharma 2012-2017
Table Pfizer Company Profile
Table Alzheimer’s Disease Drug Product Introduction of Pfizer
Table Alzheimer’s Disease Drug Production (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Pfizer 2012-2017
Table Johnson & Johnson Company Profile
Table Alzheimer’s Disease Drug Product Introduction of Johnson & Johnson
Table Alzheimer’s Disease Drug Production (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Johnson & Johnson 2012-2017
Table Lundbeck Company Profile
Table Alzheimer’s Disease Drug Product Introduction of Lundbeck
Table Alzheimer’s Disease Drug Production (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Lundbeck 2012-2017
Figure Global Alzheimer’s Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
Figure Global Alzheimer’s Disease Drug Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
Figure Global Alzheimer’s Disease Drug Price and Trend Forecast (2017-2022)
Table Global Alzheimer’s Disease Drug Sales (M Units) Forecast by Regions (2017-2022)
Figure North America Alzheimer’s Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
Figure North America Alzheimer’s Disease Drug Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Europe Alzheimer’s Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
Figure Europe Alzheimer’s Disease Drug Revenue and Growth Rate (%) Forecast (2017-2022)
Figure China Alzheimer’s Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
Figure China Alzheimer’s Disease Drug Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Japan Alzheimer’s Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
Figure Japan Alzheimer’s Disease Drug Revenue and Growth Rate (%) Forecast (2017-2022)
Table Global Alzheimer’s Disease Drug Sales (M Unit) Forecast by Type (2017-2022)
Table Global Alzheimer’s Disease Drug Revenue (M USD) Forecast by Type (2017-2022)
Table Global Alzheimer’s Disease Drug Price (USDUnit) Forecast by Type (2017-2022)
Table Global Alzheimer’s Disease Drug Sales (M Units) Forecast by Application (2017-2022)
Figure Agents currently in clinical trials for AD
Table Agents currently in phase III of development and their mechanism of action
Table Agents currently in phase II of AD drug development and their mechanism of action
Table Agents currently in phase I of development and their mechanism of action
Table Percent of trials with specific biomarkers included
Figure Marketing Channel for Alzheimer’s Disease
Figure Alzheimer’s Disease Marketing Channel
Table DistributorsTraders List
Table Research ProgramsDesign for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources